Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lymphangioma × Tablets × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 2 Vomiting 1 Vascular Malformations 1 Resectable Pancreatic Ductal Adenocarcinoma 1 Prostatic Neoplasms 1 Postoperative Hemorrhage 1 Postoperative Complications 1 Neoplasms 1 Nausea 1 Myofibroma 1 Myasthenia Gravis 1 Microbiota 1 Melanoma 1 Lymphangioma 1 Leiomyoma 1 Hepatitis B 1 Hand-Foot Skin Reaction (HFSR) 1 Glioblastoma 1 Erectile Dysfunction 1 Carcinoma, Non-Small-Cell Lung 1 Blood Loss, Surgical 1

Interventions

Tablets 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06160739 2023-12-15

Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations

Sohag University

Lymphangioma, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡